Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS
Clinical trial NCT01607645 · TERMINATED
Trial details
- NCT number
- NCT01607645
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2013-07-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.